Windlas Biotech Limited (NSE:WINDLAS)
India · Delayed Price · Currency is INR 1,129.50
+0.10 (0.01%)
Sep 11, 2026, 3:30 PM IST
Windlas Biotech Market Cap
Windlas Biotech has a market cap or net worth of 23.3 billion as of September 11, 2026. Its market cap has increased by 12.06% in one year.
Market Cap
23.30B
Enterprise Value
20.87B
Revenue
9.42B
Ranking
n/a
PE Ratio
36.27
Stock Price
1,129.50
ChartMarket Cap Chart
Since August 16, 2021, Windlas Biotech's market cap has increased from 8.87B to 23.30B, an increase of 162.62%. That is a compound annual growth rate of 20.96%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 23.30B | 39.85% |
| Dec 31, 2025 | 16.66B | -23.42% |
| Dec 31, 2024 | 21.76B | 144.02% |
| Dec 29, 2023 | 8.92B | 66.28% |
| Dec 30, 2022 | 5.36B | -10.83% |
| Dec 31, 2021 | 6.01B | -32.22% |
| Aug 16, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sun Pharma Advanced Research Company | 63.90B |
| Orchid Pharma | 51.54B |
| RPG Life Sciences | 46.02B |
| Solara Active Pharma Sciences | 34.12B |
| Ind-Swift Laboratories | 32.83B |
| Sakar Healthcare | 24.86B |
| Indoco Remedies | 23.47B |
| Beta Drugs | 21.06B |